ArticleFrontiers in cardiovascular medicine2026
Spontaneous coronary artery dissection in an underrepresented region: insights from the Serbian (RS) SCAD registry.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Evidence on spontaneous coronary artery dissection (SCAD) is largely derived from Western registries, with limited data from Eastern transitional regions. The Serbian SCAD Registry provides the first comprehensive multicenter data from this region. Methods: Patients with angiographically confirmed SCAD were enrolled from 14 PCI centers and followed during hospitalization, at 30 days, and at 1 year. Results: Among 123 patients (mean age 47.8 ± 11.8 years; 85.4% female), traditional cardiovascular risk factors were highly prevalent (hypertension 49.6%, dyslipidemia 46.3%, smoking 41.5%), exceeding rates reported in Western cohorts. Emotional stress was the most common precipitating factor (38.5%). Left anterior descending artery involvement occurred in 56.1%, with Type 2a SCAD being the most frequent (42.1%). PCI was performed in 51.3%, and dual antiplatelet therapy was prescribed in 87%, both substantially higher than in Western registries.In-hospital MACE occurred in 23.6% (mortality 8.1%). At 30 days, minor adverse events were observed, while one-year MACE was 8.2%. Conclusions: This Eastern European SCAD cohort demonstrates a distinct profile characterized by a high burden of traditional cardiovascular risk factors, frequent PCI use, and elevated in-hospital adverse events compared with Western registries. Greater adherence to guideline-based conservative management may improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.